NanO2 for Large Vessel Occlusion Stroke

Clinical trial NCT05389748 · UNKNOWN

Trial details

NCT number: NCT05389748
Sponsor: NuvOx LLC
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Ischemic Stroke

Start date: 2023-04-01
Primary completion: 2025-04-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.